Related references
Note: Only part of the references are listed.Characteristics and treatment regimens across ERS SHARP severe asthma registries
Job J. M. H. van Bragt et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma Patients
Levi B. Richards et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
An overview of clinical decision support systems: benefits, risks, and strategies for success
Reed T. Sutton et al.
NPJ DIGITAL MEDICINE (2020)
Role of Biologics in Asthma
Mary Clare McGregor et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
The Severe Asthma Network in Italy: Findings and Perspectives
Enrico Heffler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Comparison and Modelling of Country-level Microblog User and Activity in Cyber-physical-social Systems Using Weibo and Twitter Data
Po Yang et al.
ACM TRANSACTIONS ON INTELLIGENT SYSTEMS AND TECHNOLOGY (2019)
Real-world characteristics and disease burden of patients with asthma prior to treatment initiation with mepolizumab or omalizumab: a retrospective cohort database study
Jean-Pierre Llanos et al.
JOURNAL OF ASTHMA AND ALLERGY (2019)
Federated learning of predictive models from federated Electronic Health Records
Theodora S. Brisimi et al.
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS (2018)
The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research
Ratko Djukanovic et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Non-eosinophilic asthma: current perspectives
Ignacio Esteban-Gorgojo et al.
JOURNAL OF ASTHMA AND ALLERGY (2018)
Share Paper
